Introduction
Opportunistic infections caused by Candida species are particularly common in immunocompromised patients (1) . It is known that more than 90% of Human Immunodeficiency Virus-infected patients (HIV-positive patients) suffer from oral candidiasis at some point during their disease (2, 3) .
Many antifungal agents are available for the treatment of candidiasis, such as polyenes, azoles and the DNAanalogue 5-fluorocytosine. Despite the availability of such an array of agents, failure of therapy is not uncommon (4, 5) . Different studies have suggested the resistance of some C. albicans strains from HIV-positive patients to antifungal agents (6) (7) (8) (9) . Propolis is a resinous hive product collected by bee from tree buds and mixed with secreted beeswax. The propolis is used by bees as a glue to seal the opening of the hives (10) , and thus being considered a natural antibiotic (11) . Propolis has been used as a therapeutic agent by the world population since the time of Hippocrates (12) . It is known that the ethanolic extract of propolis (EPE) exhibits some pharmacological activities, such as antibacterial, antiviral, antifungal, anti-inflammatory , anesthetic and cytostatic properties (13) (14) (15) . A number of investigations have shown the antimicrobial activity of propolis against various pathogenic microorganisms (10, 16, 17) . Furthermore, earlier reports demonstrated that the EPE inhibited the in vitro growth of Candida albicans (18) (19) (20) .
Therefore, pharmacological applications of propolis preparations have led to an increased interest in its chemical composition. So far, polyphenolic compounds, e.g. flavonoid aglycones, phenolic acids and their esters , and phenolic aldehydes, have been mainly identified in propolis collected by bees in different regions (21) . The flavonoid aglycones have been considered the main active substance in propolis. However, the composition of propolis is quantitatively and qualitatively variable, depending on area and ecology (10, 20, 22, 23) . The composition of propolis can affect their biological activity. Considering that in Brazil the EPE is not recognized as a medicine, the access of population is made easy by the low price of the product in market and this same population uses it discriminated, the aim of the present paper was to evaluate the susceptibility of Candida albicans from HIV-positive patients with oral candidiasis to a commercial 20% (EPE) and compare it to the inhibitory action of some popular antifungal agents. Table  1 and Table  2 , respectively .
There were no significant differences between the data obtained for EPE and NYS (P < 0.05). However, there was significant difference between NYS and other antifungal agents. Strains PR9 and PR11 of C. albicans were significantly more susceptible to EPE than NYS. The mean diameters of the inhibition zones caused by EPE and NYS were similar for strains PR3, PR6, PR7 and PR8. EC showed significantly lower inhibition zones for 10 of the 12 C. albicans strains tested when compared to EPE and NYS. EC was ineffective against in vitro growth of strains PR2, PR8 and PR 11. CL and FL did not inhibit the in vitro growth of the 12 C. albicans strains tested. Double inhibition zone areas were observed around the discs, showing microorganism resistance to these antifungal agents (Fig. 1) .
However, all the strains of C. albicans collected from HIV-seronegative patients with Denture stomatitis showed significant susceptibility to all antifungals and EPE tested. When compared to EC, CL and FL, the inhibition zones were bigger and were significantly different from those seen with NYS and EPE. The inhibition zones included by AL were significantly smaller than those observed for all antifungal agents tested, included EPE. Discussion This paper studied the in vitro susceptibility of C. albicans to one 20% commercial brand ethanol extract of Brazilian propolis. The sample was used as it is presented (26) . The chemical constitution of propolis varies according to the type of bee, the geographic area of origin and the extraction and quality control methods used by each manufacturer (7) . Chemometrics has been shown quite efficient in uncovering relationships between chemical composition of a sample and its geographical origin. Forty propolis samples originating from the South and South East of Brazil were analyzed by high performance liguid chromatography (HPLC) and 18 compounds of interest were studied which included: caffeic, p-coumaric and ferulic acids, and some of their derivatives, pinobanksin, a derivative of kaempferol and five phenolic compounds (assigned as 3-preny14-hydroxycinnamic acid (PHCA); 2,2-dimethy1-6-carboxyethny1-2H-1-benzopyran (DCBEN); 3,5-dipreny1-4-hydroxycinnamic acid (DHCA); compound E (still unknown) and 6-propenoic-2,2-dimethy1-8-preny1-2H-1-benzopyran acid (DPB). Principal Component Analysis (PCA) indicated three different groups of propolis samples, having the same typical chromatogram, evaluated by HPLC. Samples from the South East group were rich in derivatives of kaempferol. Samples from the South group had a high content of DPB compound , but a low concentration of kaempferol derivatives and of DCBE compound. Samples from the South group II were characterized by a high concentration of DCBEN, DHCA, p-coumaric and DPB compounds.
Therefore, the identification of new compounds in Brazilian propolis can give useful information about the plant sources of a given geographic area (27) .
Several studies have demonstrated the antimycotic effect of propolis (11, 28) . Velikova et al. (29) tested twenty-one propolis samples produced by 12 different Meliponinae species which were analyzed by GC-MS. Several chemical types of stingless bees' propolis could be grouped, according to the prevailing type of compounds like: "gallic acid," "diterpenic" and "triterpenic" types. The results confirm that neither the bee species nor the geographical location determine the chemical composition of Meliponinae propolis and the choice of its plant source, respectively. This could be explained by the fact that Meliponinae forage over short distances (maximum 500 m) and thus use as propolis source the first plant exudate they found during their flights. The antibacterial, antifungal and cytotoxic activities of the samples were also investigated. Most samples had weak or no activity against E. coli, and weak action against Candida albicans. Some of them showed significant activity against S. aureus, presumably connected to the high concentration of diterpenic acids.
Several investigators have demonstrated the antifungal action of propolis against C.albicans (12,30), but few workers have documented the effect of the antifungal activity of Brazilian propolis on in vitro growth of C . albicans of HIV-seropositive Brazilian patients. The mean inhibition zones caused by the positive control (NYS) in all Candida species tested corresponded to the pattern previously defined in the literature (4, 31) . The C. albicans resistance to EC, CL and FL observed in this work is explained by the fact that the HIV-positive patients have already been treated with these antifungal agents. The zones of inhibition induced by EPE were similar to those observed for NYS, with no significant difference in HIVpositive C.albicans inhibition. However, the EPE mechanism of action on C.albicans needs more studies . The mechanism of the antimicrobial action of propolis seems to be complex and is not completely understood . According to Amoros et al. (32) and Bonhevi et al . (17) , its activity against microorganisms is more related to the synergistic effect of flavonoids (and other phenolics) than to the individual compounds. These findings are in agreement with those of Takaisikikuni and Schilcher (33) , who observed that the antibacterial action against Strep. agalactiae was complex, involving several mechanisms such as the formation of pseudomulticellular streptococci; disorganization of the cytoplasm, the cytoplasmatic (1) to (4) were active against T.cruzi. With the exception of (1), all compounds presented activity against the bacteria tested. However, the mechanism of action of propolis was not known until now.
De Paula et al. (35) demonstrated that 7 of the 14 Brazilian brands of ethanol extract solutions of propolis tested presented a pattern of inhibition similar to NYS against the "in vitro" growth of C. albicans. The author previously demonstrated that EPE induced zones of inhibition varied according to different C. albicans strains. The variations observed in the diameter of inhibition zones around the discs containing propolis were probably related to the type and concentration of chemical components, and also to bee species and to the geographic region where they were produced (10, 12, 27, 29, (36) (37) (38) .
Propolis is a resinous hive product collected by honeybees from various plant sources. The composition of the propolis depends upon the time, vegetation and the area of collection. Thus, quality evaluation of the propolis is important, before use in food and beverages. For this propose, methanol and water extracts of six different propolis from Brazil were studied by chromatography (39) . The authors (39) demonstrated 39 compounds with high intensity variety between Bl-M/ B1-W and B6-M/ B6-W propolis. In this study, the B5-M propolis sample represent the EPE of our experiment.
All experiments present samples of microorganism resistance to 93.29 alcohol as shown in figure l, a finding not observed with EPE. In our experiments, we used 20% EPE as a pharmaceutical solution that is sold in market. The southwestern Brazilian region is the source of the product, specifically the Minas Gerais State. According to Koo et al. (10) , there are differences in quality and quantity in chemical compounds of propolis solution collected from different areas. However, this fact does not alter the antifungal activity of the samples.
Flavonoids are well known for their antibacterial, antifungal and antiviral action and are thought to be responsible for the beneficial properties of propolis (13, 15) . Esters of phenolic acids and specially caffeates and ferulates have also been identified as antibacterial, antifungal and antiviral principles of propolis (18, 26, 40) . This is in good correlation with the action observed from propolis from many countries (20) . In the latter, however, the decrease of the phenolic compounds content is not accompained by a decrease of activity. Obviously, there are other compounds that contribute to the biological activity in this case. The triterpenes (lanosterol, cycloarterol, -amyrine and one of its isomers), might play a role, but there could be other active princples, still unidentified. Brazilian prolpolis samples, including those from indigenous bees, contained little or no phenolic acid esters, and most of them contained only traces of flavonoid aglycones. Their activities, however, were similar to those of European samples (20) . The large amounts of aromatic (prenylated derivatives of coumaric acid) and diterpenic acids might contribute to the antibacterial activity of these samples (27, 39, 41) .
Some flavonoids are considered antimicrobial, such as pinocembrin, galangin, and sakuranetin (13, 42, 43) . Osawa et al. (44) reported that kaempferol had antimicrobial activity against Strep. mutans and Act. viscosus and Cai and Wu (45) showed that kaempferol also inhibited the growth of Porph. gingivalis and Prev. intermedia. Aga et al. (41) showed that some hydroxycinnamic acid, isolated and identified in Brazilian propolis, showed antimicrobial activity against Bacillus cereus, Enterobacter aerogenes, and Arthroderma benhamiae. When the intra-pattern variations of the 12 C. albicans strains from HIV patients were compared, EPE and NYS invariably suppressed the in vitro growth of Candida species. This suggest that NYS and EPE potentiate a fundamental change by inhibiting metabolic precursors involved in C. albicans metabolism, even after exposure to the drugs, whereas the other drugs seem to be less potent.
The antifungal activity of CL, EC, FL and NYS observed in the strains collected from HIV-seronegative patients (Table 2 ) was expected and showed the efficacy of these drugs, even now confirmed in literature (9) . However, when these results and those from HIV-seropositive patients are compared, the profile of inhibition was significantly different. However, azoles are usually used in complicated cases of candidiasis when the possibility of using NYS is over (46) .
Propolis has been used as a medicine all over the world in a random, indiscriminate manner without medical indication, and is considered to belong to the cosmetic group. Thus, there is no systematization or control of its use by the population. The ethanol solution is the form most frequently available in grocery stores, pharmacies and stores specializing in apicultural products. Considering the free access of the population to propolis solutions and the fact that they are natural medicines with no therapeutic contraindication, our study suggest that EPE can be used topically in HIV patients infected by oral candidiasis.
Brazilian propolis has been studied all over the world from different viewpoints (4, 10, 47, 48) , nevertheless in vitro results cannot be directly extrapolated to in vivo biological conditions. In vivo studies should be carried out for a better evaluation of the activity of propolis against microorganisms of the Candida species, considering the dynamics of human beings as a whole, as well as the interference of systemic parameters and oral ecology.
